Clinical Trials at the Speed of COVID-19

The Centre for Health Evaluation and Outcome Sciences (CHÉOS) in partnership with the UBC School of Population and Public Health (SPPH), presents the first in a symposium series dedicated to discussing clinical trials that are timely, responsive and adaptive to emergent health emergencies.

In 2020, a novel coronavirus began to spread across the world, and saving lives meant acting quickly. New vaccines, diagnostics, and therapeutics had to be identified and tested in record time. Please join us for a conversation about lessons learned, challenges faced, and potential opportunities to mobilize a rapid response for the next global health crisis.

Our fight with COVID-19 is not over, but preparing for the future starts now.

Register today!

With speakers:

Dr. Aslam Anis, University of British Columbia
Dr. Cecilia Costiniuk, McGill University
Dr. Prabhakaran Dorairaj, Public Health Foundation of India
Dr. Srinivas Murthy, University of British Columbia
Dr. Jay Park, McMaster University
Dr. Natasha Press, University of British Columbia
Dr. Jim Russell, University of British Columbia
Dr. Peter Singer, World Health Organization

And Panelists:

Dr. Darryl Knight, President, Providence Health Care Research Institute
Dr. Gina Ogilvie, BC Centre for Disease Control
Dr. Megan Bettle, Executive Director, Clinical Trials, Canadian Institute of Health Research
Dr. Joel Singer, Program Head, Clinical Trials, Centre for Health Evaluation and Outcome Sciences (CHÉOS) and Professor at UBC’s School of Population and Public Health (SPPH)

Presented by:

The Centre for Health Evaluation and Outcome Sciences (CHÉOS) is a group of experienced health outcomes researchers and support staff who evaluate the effectiveness of health interventions in populations to understand how to improve health and transform health systems for the future.

The UBC School of Population and Public Health (SPPH) is dedicated to excellence and integrity across our full range of academic programming, paired with world-class research that spans and bridges multiple disciplines. Its ground-breaking work positively impacts population and public health practices and outcomes in communities in British Columbia and around the globe.